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Recognition and management of an allergic 
reaction/anaphylaxis
Signs and symptoms include:
Mild-moderate allergic reaction:
 • Swollen lips, face or eyes
 • Itchy/tingling mouth
 • Hives or itchy skin rash
 • Abdominal pain or vomiting
 • Sudden change in 
behaviour
ACTION:
 • Stay with the child, call for help if necessary
 • Locate adrenaline autoinjector(s)
 • Give antihistamine according to the child’s allergy treatment plan
 • Phone parent/emergency contact
Watch for signs of ANAPHYLAXIS 
(life-threatening allergic reaction):
Airway:  Persistent cough 
Hoarse voice 
Difficulty swallowing, swollen tongue
Breathing:   Difficult or noisy breathing 
Wheeze or persistent cough
Consciousness:  Persistent dizziness 
Becoming pale or floppy 
Suddenly sleepy, collapse, unconscious
IF ANY ONE (or more) of these signs are present:
1.   Lie child flat with legs raised: 
(if breathing is difficult, 
allow child to sit)
2.  Use Adrenaline autoinjector* without delay
3.  Dial 999 to request ambulance and say ANAPHYLAXIS
*** IF IN DOUBT, GIVE ADRENALINE ***
After giving Adrenaline:
1.  Stay with child until ambulance arrives, do NOT stand child up
2. Commence CPR if there are no signs of life
3. Phone parent/emergency contact 
4.  If no improvement after 5 minutes, give a further dose of 
adrenaline using another autoinjector device, if available.
Anaphylaxis may occur without initial mild signs: ALWAYS use adrenaline 
autoinjector FIRST in someone with known food allergy who has 
SUDDEN BREATHING DIFFICULTY (persistent cough, hoarse voice, 
wheeze) – even if no skin symptoms are present.
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Schools may administer their “spare” adrenaline auto-injector (AAI), obtained, without 
prescription, for use in emergencies, if available, but only to a pupil at risk of anaphylaxis, 
where both medical authorisation and written parental consent for use of the spare AAI has 
been provided.
The school’s spare AAI can be administered to a pupil whose own prescribed AAI cannot be 
administered correctly without delay.
AAIs can be used through clothes and should be injected into the upper outer thigh in line 
with the instructions provided by the manufacturer.
If someone appears to be having a severe allergic reaction (anaphylaxis), you MUST call 999 
without delay, even if they have already used their own AAI device, or a spare AAI.
In the event of a possible severe allergic reaction in a pupil who does not meet these criteria, 
emergency services (999) should be contacted and advice sought from them as to whether 
administration of the spare emergency AAI is appropriate.
Practical points:
 • When dialling 999, give clear and precise directions to the emergency operator, 
including the postcode of your location.
 • If the pupil’s condition deteriorates and a second dose adrenaline is administered after 
making the initial 999 call, make a second call to the emergency services to confirm 
that an ambulance has been dispatched.
 • Send someone outside to direct the ambulance paramedics when they arrive.
 • Tell the paramedics:
 – if the child is known to have an allergy;
 – what might have caused this reaction e.g. recent food;
 – the time the AAI was given.
The guidance in this document has been developed in conjunction with representatives of the 
following organisations:
 • British Society for Allergy & Clinical Immunology (Paediatric Allergy Group)
 • British Paediatric Allergy, Immunity and Infection Group
 • Royal College of Paediatrics and Child Health
 • Allergy UK
 • Anaphylaxis Campaign.
The Department of Health would like to thank Dr. Paul J. Turner for his work on this guidance.
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Executive summary
From 1 October 2017 the Human Medicines (Amendment) Regulations 2017 will allow all 
schools to buy adrenaline auto-injector (AAI) devices without a prescription, for emergency 
use in children who are at risk of anaphylaxis but their own device is not available or not 
working (e.g. because it is broken, or out-of-date).
The school’s spare AAI should only be used on pupils known to be at risk of anaphylaxis, for 
whom both medical authorisation and written parental consent for use of the spare AAI has 
been provided.
The school’s spare AAI can be administered to a pupil whose own prescribed AAI cannot be 
administered correctly without delay.
An anaphylactic reaction always requires an emergency response
Any AAI(s) held by a school should be considered a spare / back-up device and not a 
replacement for a pupil’s own AAI(s). Current guidance from the Medicines and Healthcare 
Products Regulatory Agency (MHRA) is that anyone prescribed an AAI should carry two of 
the devices at all times. This guidance does not supersede this advice from the MHRA,1 and 
any spare AAI(s) held by a school should be in addition to those already prescribed to a pupil.
This change applies to all primary and secondary schools (including independent schools) 
in the UK. Schools are not required to hold AAI(s) – this is a discretionary change enabling 
schools to do this if they wish. Those facilities choosing to hold a spare AAI(s) should establish 
a policy or protocol for their use in line with “Supporting pupils at school with medical 
conditions: Statutory guidance for governing bodies of maintained schools and proprietors 
of academies in England”2 (Supporting Pupils), and with reference to the guidance in this 
document.
The protocol could be incorporated into the wider medical conditions policy required by 
Supporting Pupils. An effective protocol should include the following – on which this guidance 
provides advice:
 • arrangements for the supply, storage, care, and disposal of spare AAI(s) in line with 
Supporting Pupils.
1 https://www.gov.uk/drug-safety-update/adrenaline-auto-injector-advice-for-patients
2 https://www.gov.uk/government/publications/supporting-pupils-at-school-with-medical-conditions--3
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 • a register of pupils who have been prescribed an AAI(s) (or where a doctor has 
provided a written plan recommending AAI(s) to be used in the event of anaphylaxis).
 • written consent from the pupil’s parent/legal guardian for use of the spare AAI(s), as 
part of a pupil’s individual healthcare plan.
 • ensuring that any spare AAI is used only in pupils where both medical authorisation 
and written parental consent have been provided.
 • appropriate support and training for staff in the use of the AAI in line with the schools 
wider policy on supporting pupils with medical conditions.
 • keeping a record of use of any AAI(s), as required by Supporting Pupils and informing 
parents or carers that their pupil has been administered an AAI and whether this was 
the school’s spare AAI or the pupil’s own device.
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1. About this guidance
From 1 October 2017 the Human Medicines (Amendment) Regulations 2017 will allow schools 
to obtain, without a prescription, adrenaline auto-injector (AAI) devices, if they wish, for use 
in emergencies. This will be for any pupil who holds both medical authorisation and parental 
consent for an AAI to be administered. The AAI(s) can be used if the pupil’s own prescribed 
AAI(s) are not immediately available (for example, because they are broken, out-of-date, have 
misfired or been wrongly administered).
This change applies to all primary and secondary schools (including independent schools) in 
the UK. Schools are not required to hold spare AAI(s) – this is a discretionary change enabling 
schools to do this if they wish. Only those institutions described in regulation 22 of the Human 
Medicines (No.2) Regulations 2014, which amends regulation 213 of the Human Medicines 
Regulations 2012 may legally hold spare AAIs.
Regulation 8 of the Human Medicines (Amendment) Regulations 2017 amends schedule 17 of 
the Human Medicines Regulations 2012, and sets out the principles of supply to schools.
Guidance on the use of AAIs in schools
This guidance is non-statutory, and has been developed by the Department of Health with key 
stakeholders, to capture the good practice which schools in England should observe in using 
spare AAIs. Schools may wish to use this as the basis of any protocol or policy. This guidance 
does not apply to schools and childcare facilities in Wales, Northern Ireland and Scotland, 
which as devolved administrations have responsibility for issuing their own guidance for those 
facilities which wish to make use of this power (and have their own distinct policies on how 
staff may support children’s health needs in the school setting). The principles of safe usage 
of AAI(s) in this guidance however are universal and based on recognised good practice.
The Children and Families Act 2014 requires governing bodies of English schools to make 
arrangements for supporting pupils with medical conditions. This duty came into force on 
1st September 2014 and is supported by the statutory guidance Supporting Pupils.3 This 
guidance is therefore designed to be read in conjunction with Supporting Pupils, and every 
school’s protocol or policy on use of the AAI should have regard to it.
3 https://www.gov.uk/government/publications/supporting-pupils-at-school-with-medical-conditions--3
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Supporting Pupils expects schools to:
 • develop policies for supporting pupils with medical conditions and review them 
regularly.
 • develop individual healthcare plans for pupils with medical conditions that identify 
the pupil’s medical condition, triggers, symptoms, medication needs and the level of 
support needed in an emergency.
 • have procedures in place on managing medicines on the premises.
 • ensure staff are appropriately supported and trained.
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2. Introduction
Anaphylaxis is a severe and often sudden allergic reaction. It can occur when a susceptible 
person is exposed to an allergen (such as food or an insect sting). Reactions usually begin 
within minutes of exposure and progress rapidly, but can occur up to 2-3 hours later. It is 
potentially life threatening and always requires an immediate emergency response.
What can cause anaphylaxis?
Common allergens that can trigger anaphylaxis are:
 • foods (e.g. peanuts, tree nuts, milk/dairy foods, egg, wheat, fish/seafood, sesame and 
soya)
 • insect stings (e.g. bee, wasp)
 • medications (e.g. antibiotics, pain relief such as ibuprofen)
 • latex (e.g. rubber gloves, balloons, swimming caps).
The severity of an allergic reaction can be influenced by a number of factors including minor 
illness (like a cold), asthma, and, in the case of food, the amount eaten. It is very unusual 
for someone with food allergies to experience anaphylaxis without actually eating the food: 
contact skin reactions to an allergen are very unlikely to trigger anaphylaxis.
The time from allergen exposure to severe life-threatening anaphylaxis and cardio-respiratory 
arrest varies, depending on the allergen:
 • Food: While symptoms can begin immediately, severe symptoms often take 30+ 
minutes to occur. However, some severe reactions can occur within minutes, while 
others can occur over 1-2 hours after eating.4 Severe reactions to dairy foods are often 
delayed, and may mimic a severe asthma attack without any other symptoms (e.g. skin 
rash) being present.
 • Severe reactions to insect stings are often faster, occurring within 10-15 minutes.4
4 Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. Resuscitation Council (UK). 
Available at: https://www.resus.org.uk/anaphylaxis/emergency-treatment-of-anaphylactic-reactions/
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Why does anaphylaxis occur?
An allergic reaction occurs because the body’s immune system reacts inappropriately to a 
substance that it wrongly perceives as a threat. The reaction is due to an interaction between 
the substance (“allergen”) and an antibody called Immunoglobulin E (IgE). This results in the 
release of chemicals such as histamine which cause the allergic reaction. In the skin, this 
causes an itchy rash, swelling and flushing. Many children (not just those with asthma) can 
develop breathing problems, similar to an asthma attack. The throat can tighten, causing 
swallowing difficulties and a high pitched sound (stridor) when breathing in.
In severe cases, the allergic reaction can progress within minutes into a life-threatening 
reaction. Administration of adrenaline can be lifesaving, although severe reactions can require 
much more than a single dose of adrenaline. It is therefore vital to contact Emergency 
Services as early as possible. Delays in giving adrenaline are a common finding in fatal 
reactions. Adrenaline should therefore be administered immediately, at the first signs of 
anaphylaxis.
How common is anaphylaxis in schools?
Up to 8% of children in the UK have a food allergy.5 However, the majority of allergic reactions 
to food are not anaphylaxis, even in children with previous anaphylaxis. Most reactions 
present with mild-moderate symptoms, and do not progress to anaphylaxis. Fatal allergic 
reactions are rare, but they are also very unpredictable. In the UK, 17% of fatal allergic 
reactions in school-aged children happen while at school.6 Schools therefore need to consider 
how to reduce the risk of an allergic reaction, in line with Supporting Pupils. Box 1 provides a 
list of actions that schools and parents can take to reduce the risk of exposure to allergens.
5 UK Food Standards Agency. https://www.food.gov.uk/science/allergy-intolerance
6 Turner PJ, Gowland MH, Sharma V et al. Increase in hospital admissions due to anaphylaxis but no increase in 
fatalities: an analysis of UK national anaphylaxis data, 1992–2012. J Allergy Clin Immunol 2015;135:956-63. Available 
at: http://www.jacionline.org/article/S0091-6749(14)01516-4/fulltext
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Box 1: Reducing the risk of allergen exposure in children with food 
allergy7
 • Bottles, other drinks and lunch boxes provided by parents for children with food 
allergies should be clearly labelled with the name of the child for whom they are 
intended.
 • If food is purchased from the school canteen, parents should check the 
appropriateness of foods by speaking directly to the catering manager. The child 
should be taught to also check with catering staff, before purchasing.
 • Where food is provided by the school, staff should be educated about how to 
read labels for food allergens and instructed about measures to prevent cross-
contamination during the handling, preparation and serving of food. Examples 
include: preparing food for children with food allergies first; careful cleaning (using 
warm soapy water) of food preparation areas and utensils.
 • Food should not be given to food-allergic children in primary schools without 
parental engagement and permission (e.g. birthday parties, food treats).
 • Implement policies to avoid trading and sharing of food, food utensils or food 
containers.
 • Unlabelled food poses a potentially greater risk of allergen exposure than packaged 
food with precautionary allergen labelling suggesting a risk of contamination with 
allergen.
 • Use of food in crafts, cooking classes, science experiments and special events 
(e.g. fetes, assemblies, cultural events) needs to be considered and may need to be 
restricted depending on the allergies of particular children and their age.
 • In arts/craft, an appropriate alternative ingredient can be substituted (e.g. wheat-free 
flour for play dough or cooking). Consider substituting non-food containers for egg 
cartons.
 • When planning out-of-school activities such as sporting events, excursions (e.g. 
restaurants and food processing plants), school outings or camps, think early 
about the catering requirements of the food-allergic child and emergency planning 
(including access to emergency medication and medical care).
Treatment
While “allergy” medicines such as antihistamines can be used for mild allergic reactions, they 
are ineffective in severe reactions – only adrenaline is recommended for severe reactions 
(anaphylaxis). The adrenaline treats both the symptoms of the reaction, and also stops the 
reaction and the further release of chemicals causing anaphylaxis. However, severe reactions 
may require more than one dose of adrenaline, and children can initially improve but then 
deteriorate later. It is therefore essential to always call for an ambulance to provide 
further medical attention, whenever anaphylaxis occurs. The use of adrenaline as an 
injection into the muscle is safe and can be life-saving.
7 Vale S, Smith J, Said M, Mullins RJ, Loh R. ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools 
and childcare: 2015 update. J Paediatr Child Health. 2015 Oct;51(10):949-54.
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Children and young people diagnosed with allergy to foods or insect stings are frequently 
prescribed AAI devices, to use in case of anaphylaxis. AAIs (current brands available in the 
UK are EpiPen®, Emerade®, Jext®) contain a single fixed dose of adrenaline, which can be 
administered by non-healthcare professionals such as family members, teachers and first-aid 
responders.
Children at risk of anaphylaxis should have their prescribed AAI(s) at school for use in an 
emergency. The MHRA recommends that those prescribed AAIs should carry TWO devices 
at all times, as some people can require more than one dose of adrenaline and the AAI device 
can be used wrongly or occasionally misfire.
Depending on their level of understanding and competence, children and particularly 
teenagers should carry their AAI(s) on their person at all times or they should be 
quickly and easily accessible at all times. If the AAI(s) are not carried by the pupil, then 
they should be kept in a central place in a box marked clearly with the pupil’s name but 
NOT locked in a cupboard or an office where access is restricted.
It is not uncommon for schools (often primary schools) to request a pupil’s AAI(s) are left in 
school to avoid the situation where a pupil or their family forgets to bring the AAI(s) to school 
each day. Where this occurs, the pupil must still have access to an AAI when travelling to and 
from school.
Further Information
There are a number of resources which provide information on allergies and anaphylaxis, 
and how they can be treated listed in section 7 together with contact details for support 
organisations. This guidance is not intended to be a detailed guide to the diagnosis or 
treatment of anaphylaxis in general. If any member of staff has reason to suspect a pupil has 
an allergy, they should notify the parents, so they can take their child to a doctor. Section 5 
gives advice on what to do in the event of an allergic reaction.
Incorporating into existing School Policy
A school’s medical conditions policy or allergy policy may already cover elements of the 
AAI protocol, for example ensuring appropriate support and training for teachers. Policies 
will likely already cover elements such as arrangements for storage, care and disposal of 
medication, ensuring written consent for administration or supervision of administration of 
medication, keeping a record of administration of medication, and informing parents in relation 
to children’s own inhalers, and could simply be expanded to cover the emergency AAI.
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3.  Arrangements for the supply, storage, 
care and disposal of AAIs
Supply
Schools can purchase AAIs from a pharmaceutical supplier, such as a local pharmacy, 
without a prescription, provided the general advice relating to these transactions are 
observed: i.e. small quantities on an occasional basis and the school does not intend to 
profit from it. A supplier will need a request signed by the principal or head teacher (ideally on 
appropriate headed paper) stating:
 • the name of the school for which the product is required;
 • the purpose for which that product is required, and
 • the total quantity required.
A template letter which can be used for this purpose is provided in Appendix 1, and can also 
be downloaded at: www.sparepensinschools.uk Please note that pharmacies are not required 
to provide AAIs free of charge to schools: the school must pay for them as a retail item.
A number of different brands of AAI are available in different doses depending on the 
manufacturer. It is up to the school to decide which brand(s) to purchase. Schools are 
advised to hold an appropriate quantity of a single brand of AAI device to avoid confusion 
in administration and training. Where all pupils are prescribed the same device, the school 
should obtain the same brand for the spare AAI. If two or more brands are currently held by 
the school, the school may wish to purchase the brand most commonly prescribed to its 
pupils. However, the decision as to how many devices and brands to purchase will depend 
on local circumstances and is left to the discretion of the school.
AAIs are available in different doses, depending on the manufacturer. The Resuscitation 
Council (UK) recommends that healthcare professionals treat anaphylaxis using the age-
based criteria,8 as follows:
 • For children age under 6 years: a dose of 150 microgram (0.15 milligram) of 
adrenaline is used (e.g. using an Epipen Junior (0.15mg), Emerade 150 or Jext 
150 microgram device).
 • For children age 6-12 years: a dose of 300 microgram (0.3 milligram) of adrenaline is 
used (e.g. using an Epipen (0.3mg), Emerade 300 or Jext 300 microgram device).
8 Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. Resuscitation Council (UK). 
Available at: https://www.resus.org.uk/anaphylaxis/emergency-treatment-of-anaphylactic-reactions/
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 • For teenagers age 12+ years: a dose of 300 or 500 microgram (Emerade 500) can be 
used.
In the context of supplying schools rather than individual pupils with AAIs for use in an 
emergency setting, using these same age-based criteria avoids the need for multiple devices/
doses, thus reducing the potential for confusion in an emergency. Schools should consider 
the ages of their pupils at risk of anaphylaxis, when deciding which doses to obtain as the 
spare AAI. Schools may wish to seek appropriate medical advice when deciding which AAI 
device(s) are most appropriate.
The emergency anaphylaxis kit
It is good practice for schools holding spare AAIs to store these as part of an emergency 
anaphylaxis kit which should include:
 • 1 or more AAI(s).
 • Instructions on how to use the device(s).
 • Instructions on storage of the AAI device(s).
 • Manufacturer’s information.
 • A checklist of injectors, identified by their batch number and expiry date with monthly 
checks recorded.
 • A note of the arrangements for replacing the injectors.
 • A list of pupils to whom the AAI can be administered.
 • An administration record.
Schools might like to keep the emergency kit together with an “emergency asthma inhaler kit” 
(containing a salbutamol inhaler device and spacer).9 Many food-allergic children also have 
asthma, and asthma is a common symptom during food-induced anaphylaxis.
Severe anaphylaxis is an extremely time-critical situation: delays in administering adrenaline 
have been associated with fatal outcomes. Schools should ensure that all AAI devices – 
including those belonging to a younger child, and any spare AAI in the Emergency kit – are 
kept in a safe and suitably central location: for example, the school office or staffroom 
to which all staff have access at all times, but in which the AAI is out of the reach and sight 
of children. They must not be locked away in a cupboard or an office where access is 
restricted. Schools should ensure that AAIs are accessible and available for use at all times, 
and not located more than 5 minutes away from where they may be needed. In larger 
schools, it may be prudent to locate a kit near the central dining area and another near the 
playground; more than one kit may be needed.
Any spare AAI devices held in the Emergency Kit should be kept separate from any pupil’s 
own prescribed AAI which might be stored nearby; the spare AAI should be clearly labelled to 
avoid confusion with that prescribed to a named pupil.
9 https://www.gov.uk/government/publications/emergency-asthma-inhalers-for-use-in-schools
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Storage and care of the AAI
A school’s allergy/anaphylaxis policy should include staff responsibilities for maintaining the 
spare anaphylaxis kit. It is recommended that at least two named volunteers amongst school 
staff should have responsibility for ensuring that:
 • on a monthly basis the AAIs are present and in date.
 • that replacement AAIs are obtained when expiry dates approach (this can be facilitated 
by signing up to the AAI expiry alerts through the relevant AAI manufacturer).
The AAI devices should be stored at room temperature (in line with manufacturer’s guidelines), 
protected from direct sunlight and extremes of temperature.
Schools may wish to require parents to take their pupil’s own prescribed AAIs home before 
school holidays (including half-term breaks) to ensure that their own AAIs remain in date and 
have not expired.
Disposal
Once an AAI has been used it cannot be reused and must be disposed of according to 
manufacturer’s guidelines. Used AAIs can be given to the ambulance paramedics on arrival or 
can be disposed of in a pre-ordered sharps bin for collection by the local council.
School trips including sporting activities
Schools should conduct a risk-assessment for any pupil at risk of anaphylaxis taking part in 
a school trip off school premises, in much the same way as they already do so with regards 
to safe-guarding etc. Pupils at risk of anaphylaxis should have their AAI with them, and there 
should be staff trained to administer AAI in an emergency. Schools may wish to consider 
whether it may be appropriate, under some circumstances, to take spare AAI(s) obtained for 
emergency use on some trips.
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4.  Children to whom a spare AAI can be 
administered
The spare AAI in the Emergency Kit should only be used in a pupil where both medical 
authorisation and written parental consent have been provided for the spare AAI to be used 
on them. This includes children at risk of anaphylaxis who have been provided with a medical 
plan confirming this, but who have not been prescribed AAI. In such cases, specific consent 
for use of the spare AAI from both a healthcare professional and parent/guardian must be 
obtained. Such a plan is available from the British Society for Allergy and Clinical Immunology 
(BSACI).10
The school’s spare AAI can be used instead of a pupil’s own prescribed AAI(s), if these cannot 
be administered correctly, without delay
This information should be recorded in a pupil’s individual healthcare plan. Where a pupil has 
no other healthcare needs other than a risk of anaphylaxis, schools may wish to consider 
using the BSACI Allergy Action Plan10. All children with a diagnosis of an allergy and at risk of 
anaphylaxis should have a written Allergy Management Plan.
Procedures should already be in place to ensure that schools are notified of pupils that have 
additional health needs, and this information will enable them to compile an allergy register. 
Some schools will already have such a register as part of their medical conditions policy.
The register could include:
 • Known allergens and risk factors for anaphylaxis.
 • Whether a pupil has been prescribed AAI(s) (and if so what type and dose).
 • Where a pupil has been prescribed an AAI whether parental consent has been given 
for use of the spare AAI which may be different to the personal AAI prescribed for the 
pupil.
 • A photograph of each pupil to allow a visual check to be made (this will require parental 
consent).
The register is crucial as in larger schools (and secondary schools in particular), it may not 
be feasible for individual members of staff to be aware of which pupils have been prescribed 
AAIs. Consequently, schools should ensure that the register is easy to access and easy 
to read. Schools will also need to ensure they have a proportionate and flexible approach 
to checking the register. DELAYS IN ADMINISTERING ADRENALINE HAVE BEEN 
10 http://www.sparepensinschools.uk/plans or http://www.bsaci.org/about/pag-allergy-action-plans-for-children
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ASSOCIATED WITH FATAL OUTCOMES. Allowing pupils to keep their AAIs with them will 
reduce delays, and allows for confirmation of consent without the need to check the register.
Schools will want to consider when consent for use of the AAI is best obtained but the most 
appropriate time would be as part of the introduction or development of the individual care 
plan. Consent should be updated regularly – ideally annually – to take account of changes to 
a pupil’s condition.
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5.  Responding to the symptoms of an 
allergic reaction
AAIs are intended for use in emergency situations when an allergic individual is having a 
reaction consistent with anaphylaxis, as a measure that is taken until an ambulance arrives. 
Therefore, unless directed otherwise by a healthcare professional, the spare AAI should only 
be used on pupils known to be at risk of anaphylaxis, where both medical authorisation and 
written parental consent for use of the spare AAI ha been provided.
This information should be recorded in a pupil’s individual healthcare plan which should be 
signed by a healthcare professional and kept in the schools allergy register.
In the event of a possible severe allergic reaction in a pupil who does not meet these criteria, 
emergency services (999) should be contacted and advice sought from them as to whether 
administration of the spare emergency AAI is appropriate.
It is recommended the school allergy policy includes general information on how to recognise 
and respond to an allergic reaction, and what to do in emergency situations. Some schools 
will already have this information in an allergy policy or medical conditions policy. Staff should 
be aware of the difficulties younger children may have in explaining how they feel.
Further information and film clips showing adrenaline being administered can be found at: 
http://www.sparepensinschools.uk
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The signs of an allergic reaction are:
Mild-moderate allergic reaction:
 • Swollen lips, face or eyes
 • Itchy/tingling mouth
 • Hives or itchy skin rash
 • Abdominal pain or vomiting
 • Sudden change in 
behaviour
ACTION:
 • Stay with the child, call for help if necessary
 • Locate adrenaline autoinjector(s)
 • Give antihistamine according to the child’s allergy treatment plan
 • Phone parent/emergency contact
Watch for signs of ANAPHYLAXIS 
(life-threatening allergic reaction):
Airway:  Persistent cough 
Hoarse voice 
Difficulty swallowing, swollen tongue
Breathing:   Difficult or noisy breathing 
Wheeze or persistent cough
Consciousness:  Persistent dizziness 
Becoming pale or floppy 
Suddenly sleepy, collapse, unconscious
IF ANY ONE (or more) of these signs are present:
1.   Lie child flat with legs raised: 
(if breathing is difficult, 
allow child to sit)
2.  Use Adrenaline autoinjector* without delay
3.  Dial 999 to request ambulance and say ANAPHYLAXIS
*** IF IN DOUBT, GIVE ADRENALINE ***
After giving Adrenaline:
1.  Stay with child until ambulance arrives, do NOT stand child up
2. Commence CPR if there are no signs of life
3. Phone parent/emergency contact 
4.  If no improvement after 5 minutes, give a further dose of 
adrenaline using another autoinjector device, if available.
Anaphylaxis may occur without initial mild signs: ALWAYS use adrenaline 
autoinjector FIRST in someone with known food allergy who has 
SUDDEN BREATHING DIFFICULTY (persistent cough, hoarse voice, 
wheeze) – even if no skin symptoms are present.
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Mild-moderate symptoms are usually responsive to an antihistamine. The pupil does not 
normally need to be sent home from school, or require urgent medical attention. However, 
mild reactions can develop into anaphylaxis: children having a mild-moderate (non-
anaphylactic) reaction should therefore be monitored for any progression in symptoms.
What to do if any symptoms of anaphylaxis are present
Anaphylaxis commonly occurs together with mild symptoms or signs of allergy, such as an 
itchy mouth or skin rash. Anaphylaxis can also occur on its own without any mild-moderate 
signs. In the presence of any of the severe symptoms listed in the red box on page 1, it is 
vital that an adrenaline auto-injector is administered without delay, regardless of what other 
symptoms or signs may be present.
Always give an adrenaline auto-injector if there are ANY signs of anaphylaxis present.
You should administer the pupil’s own AAI if available, if not use the spare AAI. The AAI can 
be administered through clothes and should be injected into the upper outer thigh in line with 
the instructions issued for each brand of injector.
IF IN DOUBT, GIVE ADRENALINE
After giving adrenaline do NOT move the pupil. Standing someone up with anaphylaxis can 
trigger cardiac arrest. Provide reassurance. The pupil should lie down with their legs raised.11 
If breathing is difficult, allow the pupil to sit.
If someone appears to be having a severe allergic reaction, it is vital to call the emergency 
services without delay – even if they have already self-administered their own adrenaline 
injection and this has made them better. A person receiving an adrenaline injection should 
always be taken to hospital for monitoring afterwards.
ALWAYS DIAL 999 AND REQUEST AN AMBULANCE IF AN AAI IS USED.
Practical points:
 • Try to ensure that a person suffering an allergic reaction remains as still as possible, and 
does not get up or rush around. Bring the AAI to the pupil, not the other way round.
 • When dialling 999, say that the person is suffering from anaphylaxis (“ANA-FIL-AX-IS”).
 • Give clear and precise directions to the emergency operator, including the postcode of 
your location.
 • If the pupil’s condition does not improve 5 to 10 minutes after the initial injection you 
should administer a second dose. If this is done, make a second call to the emergency 
services to confirm that an ambulance has been dispatched.
 • Send someone outside to direct the ambulance paramedics when they arrive.
 • Arrange to phone parents/carer.
11 In a young pregnant person, the advice is to lie the person on their left side.
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 • Tell the paramedics:
 – if the child is known to have an allergy;
 – what might have caused this reaction e.g. recent food;
 – the time the AAI was given.
Recording use of the AAI and informing parents/carers
In line with Supporting Pupils, use of any AAI device should be recorded. This should include:
 • Where and when the REACTION took place (e.g. PE lesson, playground, classroom).
 • How much medication was given, and by whom.
 • Any person who has been given an AAI must be transferred to hospital for further 
monitoring. The pupil’s parents should be contacted at the earliest opportunity. The 
hospital discharge documentation will be sent to the pupil’s GP informing them of the 
reaction.
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6.  Staff
Any member of staff may volunteer to take on the responsibilities set out in this guidance, 
but they cannot be required to do so. These staff may already have wider responsibilities for 
administering medication and/or supporting pupils with medical conditions.
SEVERE ANAPHYLAXIS IS AN EXTREMELY TIME-CRITICAL SITUATION: DELAYS IN 
ADMINISTERING ADRENALINE HAVE BEEN ASSOCIATED WITH FATAL OUTCOMES. It 
is therefore appropriate for as many staff as possible to be trained in how to administer AAI.
In the following advice, the term ‘designated members of staff’ refers to any member of staff 
who has responsibility for helping to administer a spare AAI (e.g. they have volunteered to help 
a pupil use the emergency AAI, and been trained to do this, and are identified in the school’s 
medical conditions or allergy policy as someone to whom all members of staff may have 
recourse in an emergency.)
Schools will want to ensure there are a reasonable number of designated members of staff 
to provide sufficient coverage, including when staff are on leave. In many schools, it would be 
appropriate for there to be multiple designated members of staff who can administer an AAI 
to avoid any delay in treatment.
Schools should ensure staff have appropriate training and support, relevant to their level of 
responsibility. Supporting Pupils requires governing bodies to ensure that staff supporting 
children with a medical condition should have appropriate knowledge, and where necessary, 
support.
It would be reasonable for ALL staff to:
 • be trained to recognise the range of signs and symptoms of an allergic reaction;
 • understand the rapidity with which anaphylaxis can progress to a life-threatening 
reaction, and that anaphylaxis may occur with prior mild (e.g. skin) symptoms;
 • appreciate the need to administer adrenaline without delay as soon as anaphylaxis 
occurs, before the patient might reach a state of collapse (after which it may be too late 
for the adrenaline to be effective);
 • be aware of the anaphylaxis policy;
 • be aware of how to check if a pupil is on the register;
 • be aware of how to access the AAI;
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 • be aware of who the designated members of staff are, and the policy on how to access 
their help.
Schools must arrange specialist anaphylaxis training for staff where a pupil in the school 
has been diagnosed as being at risk of anaphylaxis. The specialist training should include 
practical instruction in how to use the different AAI devices available. Online resources and 
introductory e-learning modules can be found at http://www.sparepensinschools.uk, although 
this is NOT a substitute for face-to-face training.
As part of the medical conditions policy, the school should have agreed arrangements in 
place for all members of staff to summon the assistance of a designated member of staff, to 
help administer an AAI, as well as for collecting the spare AAI in the emergency kit. These 
should be proportionate, and flexible – and can include phone calls being made to another 
member of staff or responsible secondary school-aged children asking for the assistance 
of another member of staff and/or collecting the AAI (but not checking the register), and 
procedures for supporting a designated staff member’s class while they are helping to 
administer an AAI.
DELAYS IN ADMINISTERING ADRENALINE HAVE BEEN ASSOCIATED WITH FATAL 
OUTCOMES. Thought should be given to where delays could occur (for example, a phone 
call is made to summon help but there is no answer).
The school’s policy should include a procedure for allowing a quick check of the register as 
part of initiating the emergency response. This does not necessarily need to be undertaken 
by a designated member of staff, but there may be value in a copy of the register being held 
by at least each designated member. If the register is relatively succinct, it could be held 
in every classroom. Alternatively, allowing pupils to keep their AAI(s) with them will reduce 
delays, and allows for confirmation of consent without the need to check the register.
Designated members of staff should be trained in:
 • recognising the range of signs and symptoms of severe allergic reactions;
 • responding appropriately to a request for help from another member of staff;
 • recognising when emergency action is necessary;
 • administering AAIs according to the manufacturer’s instructions;
 • making appropriate records of allergic reactions.
Training material
It is recommended that schools should also ensure that:
 • a named individual is responsible for overseeing the protocol for use of the spare AAI, 
and monitoring its implementation and for maintaining the allergy register;
 • at least two individuals are responsible for the supply, storage care and disposal of 
the AAI.
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Liability and indemnity
Supporting pupils requires that governing bodies ensure that when schools are supporting 
pupils with medical conditions, they have appropriate levels of insurance in place to cover 
staff, including liability cover relating to the administration of medication. The only exception 
will be where the actions of the employee amount to serious and wilful misconduct. 
Carelessness, inadvertence or a simple mistake do not amount to serious and wilful 
misconduct.
Local Authorities may provide schools which are administering AAIs with appropriate 
indemnity cover; however schools will need to agree any such indemnity cover directly with 
the relevant authority. Proprietors of academies should ensure that either the appropriate level 
of insurance is in place or that the academy is a member of the Department for Education’s 
Risk Protection Arrangement (RPA).
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7. Useful Links
 • Spare Pens in Schools http://www.sparepensinschools.uk
 • Official guidance relating to supporting pupils with medical needs in schools:
 – Supporting pupils at school with medical conditions. Statutory guidance for 
governing bodies of maintained schools and proprietors of academies in England 
(Department for Education, 2014). 
https://www.gov.uk/government/publications/supporting-pupils-at-school-with-
medical-conditions--3
 – Supporting Learners with Healthcare Needs. (Welsh Government, 2017). 
http://learning.gov.wales/resources/browse-all/supporting-learners-with-healthcare-
needs/?lang=en
 – The Administration of Medicines in Schools (Scottish Executive, 2001). 
http://www.scotland.gov.uk/Publications/2001/09/10006/File-1
 – Supporting Pupils with Medication Needs, (Department of Education, Department 
of Health, Social Services and Public Safety Northern Ireland, 2008) 
https://www.education-ni.gov.uk/articles/support-pupils-medication-needs
 • Allergy UK https://www.allergyuk.org/
 – Whole school allergy and awareness management (Allergy UK) 
https://www.allergyuk.org/schools/whole-school-allergy-awareness-and-
management
 • Anaphylaxis Campaign 
https://www.anaphylaxis.org.uk
 – AllergyWise training for schools 
https://www.anaphylaxis.org.uk/information-training/allergywise-training/for-
schools/
 – AllergyWise training for school nurses (Anaphylaxis Campaign) 
http://www.anaphylaxis.org.uk/information-resources/allergywise-training/for-
healthcare-professionals/
 • Education for Health 
http://www.educationforhealth.org
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 • Food allergy quality standards (The National Institute for Health and Care Excellence, 
March 2016) 
https://www.nice.org.uk/guidance/qs118
 • Anaphylaxis: assessment and referral after emergency treatment (The National Institute 
for Health and Care Excellence, 2011) 
https://www.nice.org.uk/guidance/cg134?unlid=22904150420167115834
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ANNEX:  Letter template to Pharmacy to 
obtain an AAI
Schools must provide a written letter when ordering “spare” back-up adrenaline auto-injector 
devices.
A sample letter is provided below, which can be printed on the school’s headed paper and 
signed by the principal or head teacher at the school. Ideally appropriate headed paper 
should be used, although this is not a legislative requirement.
In line with legislation, the order must state:
 • the name of the school for which the adrenaline auto-injector devices are required;
 • the purpose for which that devices are required; and
 • the total quantity required for each device.
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[To be completed on headed school paper]
[Date]
We wish to purchase emergency Adrenaline Auto-injector devices for use in our school/
college.
The adrenaline auto-injectors will be used in line with the manufacturer’s instructions, for the 
emergency treatment of anaphylaxis in accordance with the Human Medicines (Amendment) 
Regulations 2017. This allows schools to purchase “spare” back-up adrenaline auto-injectors 
for the emergency treatment of anaphylaxis. (Further information can be found at https://www.
gov.uk/government/consultations/allowing-schools-to-hold-spare-adrenaline-auto-injectors).
Please supply the following devices:
Brand name* Dose* (state milligrams or 
micrograms)
Quantity 
required
Adrenaline auto-injector device
Adrenaline auto-injector device
Signed: ___________________________________  Date: ____________________
Print name: 
Head Teacher/Principal
*AAIs are available in different doses and devices. Schools may wish to purchase the brand 
most commonly prescribed to its pupils (to reduce confusion and assist with training). 
Guidance from the Department of Health to schools recommends:
For children age under 6 years: For children age 6-12 years: For teenagers age 12+ years:
Epipen Junior (0.15mg) or
Emerade 150 microgram or
Jext 150 microgram
Epipen (0.3 milligrams) or
Emerade 300 microgram or
Jext 300 microgram
Epipen (0.3 milligrams) or
Emerade 300 microgram or
Emerade 500 microgram or
Jext 300 microgram
Further information can be found at http://www.sparepensinschools.uk
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